Ledger.Open graph →
SEC Form D · filed April 14, 2017

Adaptive Phage Therapeutics, Inc

Offering
$3.0M
Sold
$765K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BETHESDA, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Gregory Merril · Bethesda, MDExec · DirectorGregory Merril · Bethesda, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗